In a significant move to address growing concerns over water quality, various U.S. agencies, led by the EPA and HHS, have announced initiatives to identify and mitigate the presence of microplastics and pharmaceuticals in drinking water. The EPA has proposed designating these substances as contaminants, opening the door for potential new regulations. Meanwhile, RFK Jr. has unveiled a nationwide program aimed at studying the impact of microplastics on human health, with a funding commitment exceeding $134 million. The ARPA-H has also launched a $144 million initiative focused on the toxic effects of microplastics within the human body. These efforts underscore an increasing recognition of the need to monitor and regulate these contaminants to ensure safer drinking water for the public.